MRP1 is overexpressed in some tumour types and contributes to multidrug resistance by exporting a range of anticancer drugs from tumour cells (e.g., vincristine, doxorubicin, epirubicin, etoposide, daunorubicin, and mitoxantrone) [2]. This evidence concerns the gene ABCC1 and neoplasm.